Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials

Evidence has recently emerged on the influence of gender on the immune system. In this systematic review and meta-analysis of phase III randomized clinical trials (RCTs), we explored the impact of gender on survival in patients with advanced cancer treated with immune checkpoint inhibitors (ICIs). W...

Full description

Bibliographic Details
Main Authors: Antonino Grassadonia, Isabella Sperduti, Patrizia Vici, Laura Iezzi, Davide Brocco, Teresa Gamucci, Laura Pizzuti, Marcello Maugeri-Saccà, Paolo Marchetti, Gaetana Cognetti, Michele De Tursi, Clara Natoli, Maddalena Barba, Nicola Tinari
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Journal of Clinical Medicine
Subjects:
immune checkpoint inhibitors
anti-PD-1/PDL-1
anti-CTLA-4
gender
sex
nivolumab
pembrolizumab
atezolizumab
ipilimumab
durvalumab
Online Access:https://www.mdpi.com/2077-0383/7/12/542

Internet

https://www.mdpi.com/2077-0383/7/12/542

Similar Items